The Centre is ready to launch ZyCov-D, the first global DNA vaccine against Covid. According to a source, the government plans to purchase 60 lakh vaccines for this purpose in October.
According to a source, the government will purchase more than 28 crore vaccines by October. It includes 22 crore Covishield shots, six million Covaxin vaccine shots and 60 lakh DNA vaccine.
India’s regulatory body approved the ZyCovD vaccine in August 2020. The 3-dose, DNA-constructed vaccine is 66.6 percent effective against Covid. It uses an applicator instead of a needle to inject skin with lab-produced genetic DNA.
Zydus Cadila was to be distributed in the first week October. V.K., a member of NITI Ayog (Health), was asked about the delay in vaccine rollout. Paul stated last week that Zydus Cadila vaccine wasn’t administered with needles or conventional syringes but rather through an applicator. This will be the country’s first use of the applicator.
Paul stated, “We are working with the trainers. Applicators are used in the training programmes. We are working on logistics and will soon be offering the vaccine as part of Covid-19. ZyCoVD vaccine will be administered for the 12-18 year old age group.
India’s vaccination coverage has surpassed 96 crore as of Wednesday morning. 50,638,845 vaccine doses were administered in the 24 hours since. India is working hard to reach the milestone of 100 crore vaccines as soon as possible. According to a source, it is possible within two to three days. He said that ministers and MPs would spread the news to their constituents.
According to the Union Health Ministry data, there is still a balance of over 8.43 crore and unutilized Covid vaccination doses that can be administered in the States/UTs.